Nitric oxide stimulates cGMP formation in rat optic nerve axons, providing a specific marker of axon viability

European Journal of Neuroscience

Volumn 11, Issue 12, 1999, Pages 4367-4372

  Garthwaite, Giti ^a   Goodwin, David A ^a   Garthwaite, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

BW619C89; Ischaemia; Lamotrigine; Na+ channel; White matter

Indexed keywords

2,4 DIAMINO 5 (2,3,5 TRICHLOROPHENYL)PYRIMIDINE; CALCIUM ION; CYCLIC GMP; GUANYLATE CYCLASE; LAMOTRIGINE; NITRIC OXIDE; SIPATRIGINE; SODIUM ION; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CULTURE MEDIUM; ISCHEMIA; NERVE FIBER; NERVE FIBER DEGENERATION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RAT; SYNAPSE; WHITE MATTER;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; AXONS; BIOLOGICAL MARKERS; CELL HYPOXIA; CELL SURVIVAL; CYCLIC GMP; GLUCOSE; HYDRAZINES; IMMUNOHISTOCHEMISTRY; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITROGEN OXIDES; OPTIC NERVE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PYRIMIDINES; RATS; RATS, WISTAR;

EID: 0033428812     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1999.00874.x     Document Type: Article

References (29)

1. 2+ exchanger. J. Neurosci., 16, 545-552.
2. Christopherson, K.S. & Bredt, D.S. (1997) Nitric oxide in excitable tissues: physiological roles and disease. J. Clin. Invest., 100, 2424-2429.
3. Crespo, D. & Fernandez-Viadero, C. (1989) The microvascular system of the optic nerve in control and enucleated rats. Microvasc. Res., 38, 237-242.
4. Fern, R., Davis, P., Waxman, S.G. & Ransom, B.R. (1998) Axon conduction and survival in CNS white matter during energy deprivation: a developmental study. J. Neurophysiol., 79, 95-105.
5. Garthwaite, G., Brown, G., Batchelor, A.M., Goodwin, D.A. & Garthwaite, J. (1999) Mechanisms of ischaemic damage to central white matter axons: a quantitative histological analysis using rat optic nerve. Neuroscience, 94, 1219-1230.
6. Garthwaite, J. & Boulton, C.L. (1995) Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol., 57, 683-706.
7. Garthwaite, J. & Garthwaite, G. (1987) Cellular origins of cyclic GMP responses to excitatory amino acid receptor agonists in rat cerebellum in vitro. J. Neurochem., 48, 29-39.
8. Garthwaite, J., Southam, E., Boulton, C.L., Nielsen, E.B., Schmidt, K. & Mayer, B. (1995) Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol., 48, 184-188.
9. Gotzes, S., de Vente, J. & Muller, F. (1998) Nitric oxide modulates cGMP levels in neurons of the inner and outer retina in opposite ways. Vis. Neurosci., 15, 945-955.
10. Hobbs, A.J. (1997) Soluble guanylate cyclase: the forgotten sibling. Trends Pharmacol. Sci., 18, 484-491.
11. Ignarro, L.J. (1991) Signal transduction mechanisms involving nitric oxide. Biochem. Pharmacol., 41, 485-490.
12. Meldrum, B.S., Swan, J.H., Leach, M.J., Millan, M.H., Gwinn, R., Kadota, K., Graham, S.H., Chen, J. & Simon, R.P. (1992) Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87. Brain Res., 593, 1-6.
13. Morley, D. & Keefer, L.K. (1993) Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators. J. Cardiovasc. Pharmacol., 22, S3-S9.
14. Neufeld, A.H., Hernandez, M.R. & Gonzalez, M. (1997) Nitric oxide synthase in the human glaucomatous optic nerve head. Arch. Ophthalmol., 115, 497-503.
15. Nukuda, H., Dyck, P.J. & Karnes, J.L. (1985) Spatial distribution of capillaries in rat nerves: correlation to ischemic damage. Exp. Neurol., 87, 369-376.
16. Qi, X. & Guy, J. (1996) Localization of NADPH diaphorase/nitric oxide synthase in the optic nerve of the normal guinea pig: a light and electron microscopic study. J. Comp. Neurol., 370, 396-404.
17. Southam, E. & Garthwaite, J. (1993) The nitric oxide-cyclic GMP signalling pathway in rat brain. Neuropharmacology, 32, 1267-1277.
18. Stys, P.K. (1998) Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics. J. Cereb. Blood Flow Metab., 18, 2-25.
19. Stys, P.K. & Lopachin, R.M. (1998) Mechanisms of calcium and sodium fluxes in anoxic myelinated central nervous system axons. Neuroscience, 82, 21-32.
20. + conductance in rat optic nerve axons. Proc. Natl Acad. Sci. USA, 90, 6976-6980.
21. Tanaka, J., Markerink van Ittersum, M., Steinbusch, H.W. & de Vente, J. (1997) Nitric oxide-mediated cGMP synthesis in oligodendrocytes in the developing rat brain. Glia, 19, 286-297.
22. + channels as targets for neuroprotective drugs. Trends Pharmacol. Sci., 16, 309-316.
23. Trapp, B.D., Peterson, J., Ransohoff, R.M., Rudick, R., Mörk, S. & Bö, L. (1998) Axonal transection in the lesions of multiple sclerosis. New Engl. J. Med., 338, 278-285.
24. + channels: a rational and effective strategy against ischemic brain damage. Pharmacol. Rev., 48, 21-67.
25. Voet, D. & Voet, J.G. (1995). Biochemistry. John Wiley & Sons, Inc., New York.
26. Waxman, S.G., Black, J.A., Stys, P.K. & Ransom, B.R. (1992) Ultrastructural concomitants of anoxic injury and early post-anoxic recovery in rat optic nerve. Brain Res., 574, 105-119.
27. Wood, J. & Garthwaite, J. (1994) Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties. Neuropharmacology, 33, 1235-1244.
28. + channels in rat hippocampal neurones. Pflügers Arch., 430, 437-446.
29. + channels. Neuroscience, 73, 951-962.